Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers

Antonio Gasbarrini, Lorenza Rimassa, Armando Santoro, Bruno Daniele, Domenico Germano, Stefania Salvagni, Gianluca Masi, Giovanni Abbadessa, Maria Lamar, Terri Goldberg, Camillo Porta

Research output: Contribution to journal › Article

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers'. Together they form a unique fingerprint.

Medicine & Life Sciences